Cancer burden is typically measured through epidemiological studies and statistical data that track the incidence, prevalence, mortality, and survival rates of cancer. These studies often rely on cancer registries, which collect data on cancer cases and outcomes across populations. Additionally, economic analyses assess the direct and indirect costs associated with cancer care, including medical expenses, lost productivity, and the long-term impact on quality of life.